Loading...

Second Sight Medical Products, Inc.

EYES•NASDAQ
HealthcareMedical - Devices
$4.14
$-0.22(-5.05%)

Second Sight Medical Products, Inc. (EYES) Stock Overview

Explore Second Sight Medical Products, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for EYESStats details for EYES are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for EYESAnalyst Recommendations details for EYES are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

As of August 30, 2022, Second Sight Medical Products, Inc. was acquired by Nano Precision Medical, Inc., in a reverse merger transaction. Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.

CEO

Mr. Matthew Pfeffer

Employees

15

Headquarters

12744 San Fernando Rd Bldg 3, Sylmar, CALIFORNIA

Founded

2014

Frequently Asked Questions